Programma finale completo - SIF - Università degli Studi di Torino

109. The nitric oxide-leleasing derivative of furbiprofen HCT1026 decreases vulnerability
of nigrostriatal dopaminergic neurons to MPTP via a switch of glia proinflammatory
phenotype: implications for treatment of Parkinson's disease
L’Episcopo Francesca 1 , Testa N. 1 , Caniglia S. 1 , Tirolo C. 1 , Giaquinta G. 1 , Arcieri P. 1 , Serra
P.A. 2 , Bazzu G. 2 , Morale M. C. 1 , Impagnatiello F. 3 , Marchetti B. 1,2
1 Neuropharmacology, OASI Institute Researc and Care (IRCCS) Troina (EN), Italy and
2 Department of Pharmacology, University of Sassari, Medical School, Sassari, Italy, and
3 Nicox Research Institute, Bresso, Milano, Italy
110. Neuroinflammatory response in the acute MPTP rodent model of Parkinson's
disease: time-dependent correlation with histopathological, neurochemical and
behavioral response to nigrostriatal injury and repair
L’Episcopo Francesca 1 , Salani G. 2 , Serra P.A. 3 , Caniglia S. 1 , Tirolo C. 1 ,Giaquinta G. 1 , Testa
N. 1 , Rocchitta G. 3 , Calia G. 3 , Manca A. 3 , Morale M.C. 1 , Pluchino S. 2 , Martino G. 3 , Marchetti
B. 1,2
1 Neuropharmacology, OASI Institute for Research and Care (IRCCS) Troina (EN), Italy
2 Neuroimmunology Unit, Department of Neurology and Physiology, San Raffaele Scientific
Institute, Milano, and 3 Dept. Pharmacology, University of Sassari Medical School, Sassari,
Italy
90
111. S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein
up-regulation and relative WNT pathway disruption in cultured human neurons
Esposito Giuseppe 1 , Scuderi C. 1, 4 , De Filippis D. 2 , Iuvone T. 2 , Savani C. 1, 5 , Lu Jie 3 , Sheen
Volney 3 , Steardo L. 1
1 Department of Human Physiology and Pharmacology “Vittorio Erspamer”, University of Rome
“La Sapienza” - 2 Department of Experimental Pharmacology, University of Naples Federico
II.
3 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School,
Boston
4 Department of Pharmacological Sciences, University of Palermo. 5 Department of Human
Physiology and Pharmacology, University of Bari
112. Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor Grb2 and
Modulate ERK1,2 Signaling
Claudio Russo 5 , Nizzari M., Venezia V. 1 , Repetto E. 1 , Corsi V. 2 , Magrassi R. 2 , Gagliani M.C. 3 ,
Florio T. 1 , Schettini G. 1 , Tacchetti C. 3 , Russo T. 4 , Diaspro A. 2
1 Dip. Oncologia, Biologia e Genetica, Università di Genova, 2 Dip. Fisica, Università di Genova,
3 Dip.Medicina Sperimentale, Università di Genova, 4 Dip.Biochimica, Università di Napoli
Federico II, 5 Dip. Scienze per la Salute, Università del Molise
113. Nitric oxyde and dopaminergic system: neurochemical interactions in -amyloid
injected rats
Schiavone Stefania (a) , Lanni C. (b) , Cuomo V. (c) , Trabace L. (a) , Govoni S. (b)
(a) Dept. Biomedical Sciences, University of Foggia, Foggia, Italy; (b) Dept. of Experimental
and Applied Pharmacology, University of Pavia, Pavia, Italy; (c) Dept. of Human Physiology
and Pharmacology, Vittorio Espamer, University of Rome La Sapienza, Rome, Italy
114. Alterations of tau protein and effect of lithium salts treatment on TgCRND8 mice
Rosi Maria Cristina, Grossi C., Fiorentini A., Luccarini I., Casamenti F.
Department of Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
pag_sx.indd 1 30/05/2007 4.18.41